DK302388D0 - Proteiner - Google Patents

Proteiner

Info

Publication number
DK302388D0
DK302388D0 DK302388A DK302388A DK302388D0 DK 302388 D0 DK302388 D0 DK 302388D0 DK 302388 A DK302388 A DK 302388A DK 302388 A DK302388 A DK 302388A DK 302388 D0 DK302388 D0 DK 302388D0
Authority
DK
Denmark
Prior art keywords
analogs
domain
native
diluent
substitutions
Prior art date
Application number
DK302388A
Other languages
English (en)
Other versions
DK302388A (da
Inventor
Eileen Mulvihill
Shinji Yoshitake
Yasunori Ikeda
Suguru Suzuki
Akira Hashimoto
Teruaki Yuzuriha
Bjoern Andersen Nexoe
Patrick O'hare
Original Assignee
Zymogenetics Inc
Novo Industri As
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc, Novo Industri As, Eisai Co Ltd filed Critical Zymogenetics Inc
Publication of DK302388D0 publication Critical patent/DK302388D0/da
Publication of DK302388A publication Critical patent/DK302388A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • C12N9/6459Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21069Protein C activated (3.4.21.69)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
DK302388A 1987-06-04 1988-06-03 T-pa analoger med dodificeret vaekstfaktordomaene DK302388A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5806187A 1987-06-04 1987-06-04
US16284788A 1988-03-02 1988-03-02

Publications (2)

Publication Number Publication Date
DK302388D0 true DK302388D0 (da) 1988-06-03
DK302388A DK302388A (da) 1989-02-03

Family

ID=26737188

Family Applications (1)

Application Number Title Priority Date Filing Date
DK302388A DK302388A (da) 1987-06-04 1988-06-03 T-pa analoger med dodificeret vaekstfaktordomaene

Country Status (14)

Country Link
US (1) US5403734A (da)
EP (1) EP0293936B1 (da)
JP (1) JPS6485079A (da)
KR (1) KR0135427B1 (da)
AT (1) ATE118815T1 (da)
AU (1) AU625752B2 (da)
CA (1) CA1341446C (da)
DE (1) DE3853100T2 (da)
DK (1) DK302388A (da)
ES (1) ES2069536T3 (da)
FI (1) FI101306B (da)
IE (1) IE67036B1 (da)
NO (1) NO179874C (da)
NZ (1) NZ224914A (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756093A (en) * 1985-04-22 1998-05-26 Genentech, Inc. Tissue plasminogen activator variants
US5714372A (en) * 1985-04-22 1998-02-03 Genentech, Inc. Tissue plasminogen activator variants
US5736134A (en) * 1985-04-22 1998-04-07 Genentech, In.C Tissue plasminogen activator variants
DE3851259T2 (de) * 1987-06-04 1994-12-15 Zymogenetics Inc Mutierter t-PA mit Kringle-Ersatz.
GB8815135D0 (en) * 1988-06-24 1988-08-03 British Bio Technology Proteins & nucleic acids
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5258180A (en) * 1988-09-02 1993-11-02 Genetech, Inc. Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment
US5087572A (en) * 1989-12-01 1992-02-11 Genentech, Inc. Dna encoding human plasminogen modified at the cleavage site
US5190756A (en) * 1989-12-01 1993-03-02 Genentech, Inc. Methods and materials for expression of human plasminogen variant
JPH0595786A (ja) * 1991-10-07 1993-04-20 Green Cross Corp:The 変異ヒトプロウロキナーゼ
DE10199044I2 (de) * 1992-06-03 2006-02-09 Genentech Inc Varianten des Gewebeplasminogenaktivators mit verbesserter Therapeutischer wirkung
US6706504B1 (en) 1996-11-12 2004-03-16 The Scripps Research Institute Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
CA2807749C (en) * 2010-08-05 2023-02-28 Council Of Scientific & Industrial Research Protein fusion constructs possessing thrombolytic and anticoagulant properties

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68561A (en) * 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
EP0125254A1 (en) * 1982-10-28 1984-11-21 Beecham Group Plc Enzyme derivatives and their use in the treatment of thrombosis
DK149786A (da) * 1985-04-04 1986-10-04 Beecham Group Plc Proteolytisk enzym
FR2581652B1 (fr) * 1985-04-22 1989-12-22 Genentech Inc Nouveaux mutants de l'activateur tissulaire du plasminogene humain
US4916071A (en) * 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator
JP2527454B2 (ja) * 1986-01-31 1996-08-21 ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド 新しい血栓溶解タンパク質
US5376547A (en) * 1987-01-30 1994-12-27 American Home Products Corporation Des-epidermal growth factor plasminogen activators

Also Published As

Publication number Publication date
KR0135427B1 (ko) 1998-04-23
AU1743088A (en) 1988-12-08
EP0293936A3 (en) 1989-09-20
JPH0448434B2 (da) 1992-08-06
EP0293936A2 (en) 1988-12-07
JPS6485079A (en) 1989-03-30
ES2069536T3 (es) 1995-05-16
FI882627A0 (fi) 1988-06-03
NO882454L (no) 1988-12-05
NO179874C (no) 1997-01-02
CA1341446C (en) 2003-11-18
US5403734A (en) 1995-04-04
DE3853100D1 (de) 1995-03-30
NO882454D0 (no) 1988-06-03
FI882627A (fi) 1988-12-05
NZ224914A (en) 1991-02-26
FI101306B1 (fi) 1998-05-29
AU625752B2 (en) 1992-07-16
ATE118815T1 (de) 1995-03-15
IE67036B1 (en) 1996-05-15
IE881680L (en) 1988-12-04
FI101306B (fi) 1998-05-29
DE3853100T2 (de) 1995-08-03
DK302388A (da) 1989-02-03
KR890000521A (ko) 1989-03-15
NO179874B (no) 1996-09-23
EP0293936B1 (en) 1995-02-22

Similar Documents

Publication Publication Date Title
DK302388D0 (da) Proteiner
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
DE69024965D1 (de) Dehydrodidemnin b
DK0409472T3 (da) Knoglemorfogenetisk protein
DK302288D0 (da) Proteiner
DE59005128D1 (de) t-PA pro STABILISIERUNG.
DE68901361D1 (de) Anorexigenische und hypotensive peptide.

Legal Events

Date Code Title Description
ATS Application withdrawn